Fauna Bio utilizes an AI-driven platform, Convergence™, to analyze genetic data from diverse mammalian species, enabling the discovery of novel therapeutic targets for age-related diseases and metabolic disorders. By replicating the natural disease resistance mechanisms found in these animals, the company aims to develop effective drugs that can improve human health outcomes.
Funding
$53.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
+7Founders
Product
Problem
Drug discovery for age-related diseases and metabolic disorders is slow and inefficient, often failing to translate findings from traditional model organisms to humans. Current drug development approaches do not fully leverage the potential of naturally evolved disease resistance mechanisms found in the animal kingdom.
Solution
Fauna Bio is a drug discovery company that uses its Convergence™ AI platform to analyze genetic data from diverse mammalian species, identifying novel therapeutic targets. By studying animals with extreme adaptations and natural resistance to diseases, Fauna Bio replicates these mechanisms to develop new drugs for human health. The company's approach focuses on understanding how animals resist diseases at a genetic level, paving the way for effective treatments for a wide range of conditions, including age-related diseases and metabolic disorders. Fauna Bio partners with academic institutions and space agencies to access unique data and conduct in-vivo experiments, expanding its understanding of natural disease resistance.
Target Audience
Fauna Bio's primary customers are pharmaceutical companies seeking novel drug targets and therapies for age-related diseases, metabolic disorders, and other conditions with unmet medical needs.
Features
- Convergence™ AI platform analyzes genetic data from diverse mammalian species
- Focus on identifying novel therapeutic targets based on natural disease resistance mechanisms
- Exclusive biobank of genetic data from extreme animal models
- Research programs studying hibernation, cardiac regeneration, pain tolerance, and resistance to metabolic disorders
- Partnerships with academic institutions for access to unique animal models and in-vivo experiments
- Space-focused programs to understand human metabolism and prevent muscle and bone loss